PRNP and autoimmune encephalitis: Although PrPC was previously reported to demonstrate antiinflammatory activity in a variety of contexts, including in experimental autoimmune encephalitis (33–35) and in ischemic brain injury (33, 36–38), incomplete understanding of the responsible molecular mechanism has hindered efforts to exploit this activity of PrPC in therapeutics development.